Literature DB >> 3017496

Classification of adenosine receptors mediating antinociception in the rat spinal cord.

J Sawynok, M I Sweeney, T D White.   

Abstract

Analogues of adenosine were injected intrathecally into rats implanted with chronic indwelling cannulae in order to determine a rank order of potency and hence characterize adenosine receptors involved in spinal antinociception. In the tail flick test L-N6-phenylisopropyl adenosine (L-PIA), cyclohexyladenosine (CHA) and 5'-N-ethylcarboxamide adenosine (NECA) produced dose-related antinociception which attained a plateau level. NECA and CHA also produced an additional distinct second phase of antinociception. D-N6-Phenylisopropyl adenosine (D-PIA) and 2-chloroadenosine (CADO) had very little antinociceptive activity in this test. The rank order of potency in producing the plateau effect was L-PIA greater than CHA greater than NECA greater than D-PIA = CADO, while that for the second phase of antinociception was NECA greater than-CHA. Pretreatment with both theophylline and 8-phenyltheophylline (8-PT) antagonized antinociception produced by CHA, with 8-PT being at least an order of magnitude more potent than theophylline. Both antagonists produced a significant hyperalgesia in the tail flick test. L-PIA and CHA also produced methylxanthine-sensitive antinociception in the hot plate test. These results suggest that activation of A1-receptors in the spinal cord can produce antinociception. Activation of A2-receptors may produce an additional effect, but the relative activity of CHA in this component of activity is unusual.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3017496      PMCID: PMC1917091          DOI: 10.1111/j.1476-5381.1986.tb16267.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells.

Authors:  D van Calker; M Müller; B Hamprecht
Journal:  J Neurochem       Date:  1979-11       Impact factor: 5.372

2.  Alkylxanthines: inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity.

Authors:  F W Smellie; C W Davis; J W Daly; J N Wells
Journal:  Life Sci       Date:  1979-06-25       Impact factor: 5.037

3.  Structure-activity relations for presynaptic inhibition of noradrenergic and cholinergic transmission by adenosine: evidence for action on A1 receptors.

Authors:  D M Paton
Journal:  J Auton Pharmacol       Date:  1981-09

4.  The dextro and levorotatory isomers of N-phenylisopropyladenosine: stereospecific effects on cyclic AMP-formation and evoked synaptic responses in brain slices.

Authors:  F W Smellie; J W Daly; T V Dunwiddie; B J Hoffer
Journal:  Life Sci       Date:  1979-11-12       Impact factor: 5.037

5.  Methyl xanthines, adenosine 3',5'-cyclic monophosphate and the spinal transmission of nociceptive information.

Authors:  A W Duggan; B T Griersmith
Journal:  Br J Pharmacol       Date:  1979-09       Impact factor: 8.739

6.  Stereospecificity in some central and circulatory effects of phenylisopropyl-adenosine (PIA).

Authors:  H Vapaatalo; D Onken; P J Neuvonen; E Westermann
Journal:  Arzneimittelforschung       Date:  1975-03

7.  Antagonism of presynaptic adenosine receptors by theophylline 9-beta-D-riboside and 8-phenyltheophylline.

Authors:  A S Clanachan
Journal:  Can J Physiol Pharmacol       Date:  1981-06       Impact factor: 2.273

8.  Effects of (-)-N6-(R-phenylisopropyl)-adenosine (PIA) and caffeine on nociception and morphine-induced analgesia, tolerance and dependence in mice.

Authors:  M K Ahlijanian; A E Takemori
Journal:  Eur J Pharmacol       Date:  1985-06-07       Impact factor: 4.432

9.  In vivo behavioral assessment of central nervous system purinergic receptors.

Authors:  G G Yarbrough; J C McGuffin-Clineschmidt
Journal:  Eur J Pharmacol       Date:  1981-12-03       Impact factor: 4.432

10.  8-phenyltheophylline: a potent P1-purinoceptor antagonist.

Authors:  S G Griffith; P Meghji; C J Moody; G Burnstock
Journal:  Eur J Pharmacol       Date:  1981-10-15       Impact factor: 4.432

View more
  11 in total

1.  The effect of ABT-702, a novel adenosine kinase inhibitor, on the responses of spinal neurones following carrageenan inflammation and peripheral nerve injury.

Authors:  R Suzuki; L C Stanfa; E A Kowaluk; M Williams; M F Jarvis; A H Dickenson
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  ATP-sensitive K(+) channels regulate the concentrative adenosine transporter CNT2 following activation by A(1) adenosine receptors.

Authors:  Sylvie Duflot; Bárbara Riera; Sonia Fernández-Veledo; Vicent Casadó; Robert I Norman; F Javier Casado; Carme Lluís; Rafael Franco; Marçal Pastor-Anglada
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

3.  The efficacy of a novel adenosine agonist (WAG 994) in postoperative dental pain.

Authors:  R A Seymour; J E Hawkesford; C M Hill; J Frame; C Andrews
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

4.  Adenosine analogs do not inhibit the potassium-stimulated release of substance P from rat spinal cord slices.

Authors:  M R Vasko; H Ono
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

5.  Control of glutamatergic neurotransmission in the rat spinal dorsal horn by the nucleoside transporter ENT1.

Authors:  Michael A Ackley; Ricardo J M Governo; Carol E Cass; James D Young; Stephen A Baldwin; Anne E King
Journal:  J Physiol       Date:  2003-02-28       Impact factor: 5.182

6.  Chronic intrathecal morphine treatment does not cause down-regulation of spinal adenosine A1 receptors in rats.

Authors:  P L Tao; C S Wong; M C Lin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

7.  Role of ATP-sensitive K+ channels in antinociception induced by R-PIA, an adenosine A1 receptor agonist.

Authors:  M Ocaña; J M Baeyens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-07       Impact factor: 3.000

8.  Fructose-1,6-bisphosphate reduces inflammatory pain-like behaviour in mice: role of adenosine acting on A1 receptors.

Authors:  D A Valério; F I Ferreira; T M Cunha; J C Alves-Filho; F O Lima; J R De Oliveira; S H Ferreira; F Q Cunha; R H Queiroz; W A Verri
Journal:  Br J Pharmacol       Date:  2009-07-23       Impact factor: 8.739

9.  Binary drugs: conjugates of purines and a peptide that bind to both adenosine and substance P receptors.

Authors:  K A Jacobson; A W Lipkowski; T W Moody; W Padgett; E Pijl; K L Kirk; J W Daly
Journal:  J Med Chem       Date:  1987-08       Impact factor: 7.446

Review 10.  Post-triptan era for the treatment of acute migraine.

Authors:  Peter J Goadsby
Journal:  Curr Pain Headache Rep       Date:  2004-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.